These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 355087)

  • 21. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria.
    Egashira T; Ekstedt B; Oreland L
    Biochem Pharmacol; 1976 Dec; 25(23):2583-6. PubMed ID: 985579
    [No Abstract]   [Full Text] [Related]  

  • 22. Physicochemical properties, development, and regulation of central and peripheral monoamine oxidase activity.
    Youdim MB; Holzbauer M; Woods HF
    Adv Biochem Psychopharmacol; 1974; 12(0):11-28. PubMed ID: 4608303
    [No Abstract]   [Full Text] [Related]  

  • 23. [Baygon (2-isopropoxyphenyl-N-methyl carbamate) activation of enzymatic deamination of 2-phenyl-ethylamine].
    Zeĭnalov TA
    Vopr Med Khim; 1985; 31(5):60-4. PubMed ID: 4090367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of lipid-depletion on the different forms of monoamine oxidase in rat liver mitochondria.
    Ekstedt B; Oreland L
    Biochem Pharmacol; 1976 Jan; 25(2):119-24. PubMed ID: 1259773
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The heterogeneity of monoamine oxidase in distinct populations of rat brain mitochondria.
    Owen F; Bourne R
    Biochem Pharmacol; 1977 Feb; 26(4):289-92. PubMed ID: 849318
    [No Abstract]   [Full Text] [Related]  

  • 29. [Selective inhibition of type A monoamine oxidase by pyrazidol].
    Mashkovskiĭ MD; Gorkin VZ; Verevkina IV; Asnina VV; Tupikina SM
    Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW
    Biochem Pharmacol; 1968 Oct; 17(10):2097-106. PubMed ID: 5696879
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat.
    Ask AL; Hellström W; Norrman S; Ogren SO; Ross SB
    Neuropharmacology; 1982 Apr; 21(4):299-308. PubMed ID: 7088264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase.
    Fowler CJ; Tipton KF
    Biochem Pharmacol; 1981 Dec; 30(24):3329-32. PubMed ID: 7326042
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid substitution of mitochondrial monoamine oxidase can lead to the abolition of clorgyline selective inhibition without alteration in the A/B ratio assessed by substrate utilisation.
    Houslay MD
    Biochem Pharmacol; 1980 Dec; 29(23):3211-3. PubMed ID: 7447959
    [No Abstract]   [Full Text] [Related]  

  • 34. The inhibition or rat heart type A monoamine oxidase by clorgyline as a method for the estimation of enzyme active centers.
    Fowler CJ; Callingham BA
    Mol Pharmacol; 1979 Sep; 16(2):546-55. PubMed ID: 514258
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple forms of monoamine oxidase: some in vivo correlations.
    Sandler M; Carter SB; Goodwin BL; Ruthven CR; Youdim MB; Hanington E; Cuthbert MF; Pare CM
    Adv Biochem Psychopharmacol; 1974; 12(0):3-10. PubMed ID: 4608403
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of some derivatives of piperidine, piperazine and related compounds on deamination of serotonin, tyramine and benzylamine by pig liver mitochondrial monoamine oxidase].
    Prikulis AA; Grinberga BA; Grinshteĭn VIa; Strelka GR
    Biokhimiia; 1983; 48(2):313-9. PubMed ID: 6838929
    [No Abstract]   [Full Text] [Related]  

  • 38. Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria.
    Ekstedt B
    Biochem Pharmacol; 1976 May; 25(10):1133-8. PubMed ID: 938537
    [No Abstract]   [Full Text] [Related]  

  • 39. Characteristics of monoamine oxidase in mitochondria isolated from chick brain, liver, kidney and heart.
    Suzuki O; Hattori H; Oya M; Katsumata Y
    Biochem Pharmacol; 1980 Feb; 29(4):603-7. PubMed ID: 7370053
    [No Abstract]   [Full Text] [Related]  

  • 40. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.